We then analyzed the expression patterns of KDM5B in a number of clinical samples derived from Japanese bladder cancer subjects examined by cDNA microarray (Figure 1B and 1C), and confirmed its significant overexpression (P < 0.0001, Mann-Whitney's U-test). This evidence concerns the gene KDM5B and urinary bladder carcinoma.